TreeWAS – Variant ID: rs10944479

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E03.9 Hypothyroidism, unspecified	1.000	0.000	0.000
C44 Other malignant neoplasms of skin	0.000	0.000	1.000
C44.5 Skin of trunk	0.000	0.000	1.000
E03 Other hypothyroidism	1.000	0.000	0.000
E00-E07 Disorders of thyroid gland	1.000	0.000	0.000
E10 Insulin-dependent diabetes mellitus	0.999	0.001	0.000
E10-E14 Diabetes mellitus	0.998	0.002	0.000
C44.3 Skin of other and unspecified parts of face	0.000	0.002	0.998
Chapter IV Endocrine, nutritional and metabolic diseases	0.998	0.002	0.000
E10.9 Without complications	0.997	0.003	0.000
C44.6 Skin of upper limb, including shoulder	0.000	0.006	0.994
J45.9 Asthma, unspecified	0.000	0.027	0.973
E06 Thyroiditis	0.955	0.045	0.000
E20-E35 Disorders of other endocrine glands	0.947	0.053	0.000
C44.2 Skin of ear and external auricular canal	0.000	0.054	0.946
E05 Thyrotoxicosis [hyperthyroidism]	0.943	0.057	0.000
E27 Other disorders of adrenal gland	0.931	0.069	0.000
E10.4 With neurological complications	0.924	0.076	0.000
E27.1 Primary adrenocortical insufficiency	0.923	0.077	0.000
E10.1 With ketoacidosis	0.920	0.080	0.000
E06.3 Autoimmune thyroiditis	0.913	0.087	0.000
E10.3 With ophthalmic complications	0.910	0.090	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.901	0.099	0.000
E13 Other specified diabetes mellitus	0.876	0.124	0.000
C44.0 Skin of lip	0.000	0.133	0.867
E02 Subclinical iodine-deficiency hypothyroidism	0.866	0.134	0.000
E27.2 Addisonian crisis	0.863	0.137	0.000
E34 Other endocrine disorders	0.830	0.170	0.000
C44.7 Skin of lower limb, including hip	0.000	0.200	0.800
E05.9 Thyrotoxicosis, unspecified	0.800	0.200	0.000
E10.2 With renal complications	0.800	0.200	0.000
E10.0 With coma	0.787	0.213	0.000
C44.4 Skin of scalp and neck	0.000	0.214	0.786
E22 Hyperfunction of pituitary gland	0.774	0.226	0.000
E14 Unspecified diabetes mellitus	0.767	0.233	0.000
E10.6 With other specified complications	0.764	0.236	0.000
E03.1 Congenital hypothyroidism without goitre	0.760	0.240	0.000
E34.9 Endocrine disorder, unspecified	0.743	0.257	0.000
E13.9 Without complications	0.737	0.263	0.000
E06.9 Thyroiditis, unspecified	0.731	0.269	0.000
E10.8 With unspecified complications	0.725	0.275	0.000
E40-E46 Malnutrition	0.722	0.278	0.000
E13.3 With ophthalmic complications	0.718	0.282	0.000
C44.8 Overlapping lesion of skin	0.000	0.283	0.717
E03.5 Myxoedema coma	0.717	0.283	0.000
E03.4 Atrophy of thyroid (acquired)	0.717	0.283	0.000
E03.3 Postinfectious hypothyroidism	0.717	0.283	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.717	0.283	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.717	0.283	0.000
E00 Congenital iodine-deficiency syndrome	0.717	0.283	0.000
E10.7 With multiple complications	0.716	0.284	0.000
E12 Malnutrition-related diabetes mellitus	0.716	0.284	0.000
E06.5 Other chronic thyroiditis	0.710	0.289	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.709	0.291	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.701	0.299	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.000	0.303	0.697
E03.8 Other specified hypothyroidism	0.688	0.312	0.000
E23 Hypofunction and other disorders of pituitary gland	0.686	0.313	0.000
E50-E64 Other nutritional deficiencies	0.685	0.315	0.000
E06.4 Drug-induced thyroiditis	0.685	0.315	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.685	0.315	0.000
E06.1 Subacute thyroiditis	0.685	0.315	0.000
E06.0 Acute thyroiditis	0.685	0.315	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.679	0.321	0.000
E32 Diseases of thymus	0.679	0.321	0.000
E31 Polyglandular dysfunction	0.679	0.321	0.000
E30 Disorders of puberty, not elsewhere classified	0.679	0.321	0.000
E25 Adrenogenital disorders	0.679	0.321	0.000
E05.8 Other thyrotoxicosis	0.676	0.324	0.000
E05.5 Thyroid crisis or storm	0.676	0.324	0.000
E05.4 Thyrotoxicosis factitia	0.676	0.324	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.676	0.324	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.676	0.324	0.000
E34.8 Other specified endocrine disorders	0.676	0.324	0.000
E27.5 Adrenomedullary hyperfunction	0.668	0.332	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.668	0.332	0.000
E27.0 Other adrenocortical overactivity	0.668	0.332	0.000
E14.3 With ophthalmic complications	0.639	0.361	0.000
E14.1 With ketoacidosis	0.634	0.366	0.000
E13.8 With unspecified complications	0.628	0.372	0.000
E13.7 With multiple complications	0.628	0.372	0.000
E13.6 With other specified complications	0.628	0.372	0.000
E13.5 With peripheral circulatory complications	0.628	0.372	0.000
E13.4 With neurological complications	0.628	0.372	0.000
E13.2 With renal complications	0.628	0.372	0.000
E13.1 With ketoacidosis	0.628	0.372	0.000
E13.0 With coma	0.628	0.372	0.000
E20 Hypoparathyroidism	0.615	0.384	0.000
E24 Cushing's syndrome	0.612	0.388	0.000
E27.8 Other specified disorders of adrenal gland	0.609	0.391	0.000
E26 Hyperaldosteronism	0.604	0.396	0.000
C44.1 Skin of eyelid, including canthus	0.000	0.396	0.604
E34.5 Androgen resistance syndrome	0.595	0.405	0.000
E34.4 Constitutional tall stature	0.595	0.405	0.000
E34.3 Short stature, not elsewhere classified	0.595	0.405	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.595	0.405	0.000
E34.1 Other hypersecretion of intestinal hormones	0.595	0.405	0.000
E14.4 With neurological complications	0.594	0.406	0.000
E23.2 Diabetes insipidus	0.587	0.413	0.000
E10.5 With peripheral circulatory complications	0.577	0.422	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.576	0.424	0.000
E07 Other disorders of thyroid	0.574	0.426	0.000
E14.6 With other specified complications	0.573	0.427	0.000
E14.2 Withrenal complications	0.555	0.444	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.555	0.445	0.000
E22.8 Other hyperfunction of pituitary gland	0.555	0.445	0.000
E14.7 With multiple complications	0.550	0.450	0.000
E14.5 With peripheral circulatory complications	0.550	0.450	0.000
E14.0 With coma	0.550	0.450	0.000
E14.8 With unspecified complications	0.546	0.454	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.544	0.456	0.000
E58 Dietary calcium deficiency	0.542	0.458	0.000
E46 Unspecified protein-energy malnutrition	0.524	0.476	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.518	0.482	0.000
E45 Retarded development following protein-energy malnutrition	0.518	0.482	0.000
E43 Unspecified severe protein-energy malnutrition	0.518	0.482	0.000
E42 Marasmic kwashiorkor	0.518	0.482	0.000
E41 Nutritional marasmus	0.518	0.482	0.000
E40 Kwashiorkor	0.518	0.482	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.514	0.486	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.514	0.486	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.514	0.486	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.514	0.486	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.514	0.486	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.514	0.486	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.514	0.486	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.514	0.486	0.000
E12.9 Without complications	0.513	0.487	0.000
E12.8 With unspecified complications	0.513	0.487	0.000
E12.7 With multiple complications	0.513	0.487	0.000
E12.6 With other specified complications	0.513	0.487	0.000
E12.5 With peripheral circulatory complications	0.513	0.487	0.000
E12.4 With neurological complications	0.513	0.487	0.000
E12.3 With ophthalmic complications	0.513	0.487	0.000
E12.2 With renal complications	0.513	0.487	0.000
E12.1 With ketoacidosis	0.513	0.487	0.000
E12.0 With coma	0.513	0.487	0.000
E22.0 Acromegaly and pituitary gigantism	0.512	0.487	0.000
E28 Ovarian dysfunction	0.510	0.490	0.000
E61 Deficiency of other nutrient elements	0.502	0.498	0.000
E29 Testicular dysfunction	0.495	0.504	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.492	0.508	0.000
E23.1 Drug-induced hypopituitarism	0.492	0.508	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.491	0.508	0.000
E63 Other nutritional deficiencies	0.491	0.508	0.000
E56 Other vitamin deficiencies	0.491	0.508	0.000
E51 Thiamine deficiency	0.491	0.508	0.000
E50 Vitamin A deficiency	0.491	0.508	0.000
E60 Dietary zinc deficiency	0.491	0.508	0.000
E59 Dietary selenium deficiency	0.491	0.508	0.000
E54 Ascorbic acid deficiency	0.491	0.508	0.000
E52 Niacin deficiency [pellagra]	0.491	0.508	0.000
J45 Asthma	0.000	0.509	0.491
E23.7 Disorder of pituitary gland, unspecified	0.487	0.512	0.000
E25.9 Adrenogenital disorder, unspecified	0.487	0.513	0.000
E25.8 Other adrenogenital disorders	0.487	0.513	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.487	0.513	0.000
E30.9 Disorder of puberty, unspecified	0.487	0.513	0.000
E30.8 Other disorders of puberty	0.487	0.513	0.000
E30.1 Precocious puberty	0.487	0.513	0.000
E30.0 Delayed puberty	0.487	0.513	0.000
E31.9 Polyglandular dysfunction, unspecified	0.487	0.513	0.000
E31.8 Other polyglandular dysfunction	0.487	0.513	0.000
E31.1 Polyglandular hyperfunction	0.487	0.513	0.000
E31.0 Autoimmune polyglandular failure	0.487	0.513	0.000
E32.9 Disease of thymus, unspecified	0.487	0.513	0.000
E32.8 Other diseases of thymus	0.487	0.513	0.000
E32.1 Abscess of thymus	0.487	0.513	0.000
E32.0 Persistent hyperplasia of thymus	0.487	0.513	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.487	0.513	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.487	0.513	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.487	0.513	0.000
E65-E68 Obesity and other hyperalimentation	0.485	0.515	0.000
E34.0 Carcinoid syndrome	0.481	0.518	0.000
E24.9 Cushing's syndrome, unspecified	0.479	0.521	0.000
E23.6 Other disorders of pituitary gland	0.478	0.522	0.000
E22.1 Hyperprolactinaemia	0.467	0.533	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.464	0.535	0.000
E53 Deficiency of other B group vitamins	0.447	0.552	0.000
E27.9 Disorder of adrenal gland, unspecified	0.444	0.556	0.001
E20.8 Other hypoparathyroidism	0.441	0.558	0.000
E20.1 Pseudohypoparathyroidism	0.441	0.558	0.000
E20.0 Idiopathic hypoparathyroidism	0.441	0.558	0.000
E24.8 Other Cushing's syndrome	0.439	0.561	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.439	0.561	0.000
E24.3 Ectopic ACTH syndrome	0.439	0.561	0.000
E24.1 Nelson's syndrome	0.439	0.561	0.000
E26.9 Hyperaldosteronism, unspecified	0.433	0.567	0.000
E26.8 Other hyperaldosteronism	0.433	0.567	0.000
E26.1 Secondary hyperaldosteronism	0.433	0.567	0.000
E55 Vitamin D deficiency	0.425	0.575	0.000
J45.0 Predominantly allergic asthma	0.000	0.579	0.421
E15 Nondiabetic hypoglycaemic coma	0.413	0.587	0.000
E07.1 Dyshormogenetic goitre	0.411	0.588	0.000
E07.0 Hypersecretion of calcitonin	0.411	0.588	0.000
E21.2 Other hyperparathyroidism	0.405	0.595	0.000
J33.9 Nasal polyp, unspecified	0.000	0.596	0.404
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.394	0.605	0.000
E07.8 Other specified disorders of thyroid	0.392	0.607	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.390	0.610	0.000
E21.4 Other specified disorders of parathyroid gland	0.390	0.610	0.000
E24.0 Pituitary-dependent Cushing's disease	0.388	0.611	0.000
E20.9 Hypoparathyroidism, unspecified	0.378	0.622	0.000
E24.2 Drug-induced Cushing's syndrome	0.372	0.628	0.000
E44.1 Mild protein-energy malnutrition	0.371	0.629	0.000
E44.0 Moderate protein-energy malnutrition	0.371	0.629	0.000
E65 Localised adiposity	0.368	0.632	0.000
E28.9 Ovarian dysfunction, unspecified	0.365	0.634	0.000
E28.8 Other ovarian dysfunction	0.365	0.634	0.000
E28.1 Androgen excess	0.365	0.634	0.000
E28.0 Oestrogen excess	0.365	0.634	0.000
E61.2 Magnesium deficiency	0.365	0.634	0.000
E61.1 Iron deficiency	0.365	0.635	0.000
E61.9 Deficiency of nutrient element, unspecified	0.360	0.640	0.000
E61.8 Deficiency of other specified nutrient elements	0.360	0.640	0.000
E61.7 Deficiency of multiple nutrient elements	0.360	0.640	0.000
E61.6 Vanadium deficiency	0.360	0.640	0.000
E61.5 Molybdenum deficiency	0.360	0.640	0.000
E61.4 Chromium deficiency	0.360	0.640	0.000
E61.3 Manganese deficiency	0.360	0.640	0.000
E61.0 Copper deficiency	0.360	0.640	0.000
E26.0 Primary hyperaldosteronism	0.358	0.642	0.000
E23.0 Hypopituitarism	0.356	0.644	0.000
E29.9 Testicular dysfunction, unspecified	0.355	0.644	0.000
E29.8 Other testicular dysfunction	0.355	0.644	0.000
E29.0 Testicular hyperfunction	0.355	0.644	0.000
E50.9 Vitamin A deficiency, unspecified	0.352	0.647	0.000
E50.8 Other manifestations of vitamin A deficiency	0.352	0.647	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.352	0.647	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.352	0.647	0.000
E50.5 Vitamin A deficiency with night blindness	0.352	0.647	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.352	0.647	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.352	0.647	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.352	0.647	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.352	0.647	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.352	0.647	0.000
E51.9 Thiamine deficiency, unspecified	0.352	0.647	0.000
E51.8 Other manifestations of thiamine deficiency	0.352	0.647	0.000
E51.2 Wernicke's encephalopathy	0.352	0.647	0.000
E51.1 Beriberi	0.352	0.647	0.000
E56.9 Vitamin deficiency, unspecified	0.352	0.647	0.000
E56.8 Deficiency of other vitamins	0.352	0.647	0.000
E56.1 Deficiency of vitamin K	0.352	0.647	0.000
E56.0 Deficiency of vitamin E	0.352	0.647	0.000
E63.9 Nutritional deficiency, unspecified	0.352	0.647	0.000
E63.8 Other specified nutritional deficiencies	0.352	0.647	0.000
E63.1 Imbalance of constituents of food intake	0.352	0.647	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.352	0.647	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.352	0.647	0.000
E64.8 Sequelae of other nutritional deficiencies	0.352	0.647	0.000
E64.3 Sequelae of rickets	0.352	0.647	0.000
E64.2 Sequelae of vitamin C deficiency	0.352	0.647	0.000
E64.1 Sequelae of vitamin A deficiency	0.352	0.647	0.000
E64.0 Sequelae of protein-energy malnutrition	0.352	0.647	0.000
E67 Other hyperalimentation	0.348	0.652	0.000
E68 Sequelae of hyperalimentation	0.348	0.652	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.339	0.661	0.001
J45.1 Nonallergic asthma	0.000	0.669	0.331
E21.3 Hyperparathyroidism, unspecified	0.329	0.671	0.000
E28.3 Primary ovarian failure	0.323	0.677	0.000
E53.1 Pyridoxine deficiency	0.321	0.679	0.000
E53.0 Riboflavin deficiency	0.321	0.679	0.000
E53.9 Vitamin B deficiency, unspecified	0.321	0.679	0.000
J45.8 Mixed asthma	0.000	0.680	0.320
E21.0 Primary hyperparathyroidism	0.307	0.693	0.000
E55.0 Rickets, active	0.304	0.695	0.000
E07.9 Disorder of thyroid, unspecified	0.300	0.700	0.000
E53.8 Deficiency of other specified B group vitamins	0.277	0.723	0.000
E16 Other disorders of pancreatic internal secretion	0.273	0.727	0.000
E04 Other non-toxic goitre	0.269	0.731	0.000
E28.2 Polycystic ovarian syndrome	0.267	0.732	0.000
E67.8 Other specified hyperalimentation	0.249	0.750	0.000
E67.3 Hypervitaminosis D	0.249	0.750	0.000
E67.2 Megavitamin-B6 syndrome	0.249	0.750	0.000
E67.1 Hypercarotenaemia	0.249	0.750	0.000
E67.0 Hypervitaminosis A	0.249	0.750	0.000
E55.9 Vitamin D deficiency, unspecified	0.237	0.762	0.000
J33 Nasal polyp	0.000	0.784	0.216
E11 Non-insulin-dependent diabetes mellitus	0.206	0.794	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.196	0.804	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.196	0.804	0.000
E16.4 Abnormal secretion of gastrin	0.196	0.804	0.000
E16.3 Increased secretion of glucagon	0.196	0.804	0.000
E16.1 Other hypoglycaemia	0.194	0.806	0.000
E04.8 Other specified non-toxic goitre	0.193	0.807	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.000	0.809	0.191
J33.0 Polyp of nasal cavity	0.000	0.817	0.183
E16.0 Drug-induced hypoglycaemia without coma	0.182	0.818	0.000
E11.3 With ophthalmic complications	0.178	0.822	0.000
E29.1 Testicular hypofunction	0.172	0.828	0.001
E11.1 With ketoacidosis	0.172	0.828	0.000
E04.0 Non-toxic diffuse goitre	0.171	0.829	0.000
E04.1 Non-toxic single thyroid nodule	0.166	0.834	0.000
J33.8 Other polyp of sinus	0.000	0.839	0.161
E11.6 With other specified complications	0.152	0.848	0.000
E11.8 With unspecified complications	0.151	0.849	0.000
E11.7 With multiple complications	0.148	0.852	0.000
E11.0 With coma	0.144	0.856	0.000
J33.1 Polypoid sinus degeneration	0.000	0.863	0.137
E14.9 Without complications	0.126	0.874	0.000
E04.2 Non-toxic multinodular goitre	0.120	0.880	0.000
E11.2 With renal complications	0.120	0.880	0.000
E04.9 Non-toxic goitre, unspecified	0.115	0.885	0.000
E16.2 Hypoglycaemia, unspecified	0.094	0.906	0.000
Z88.2 Personal history of allergy to sulphonamides	0.085	0.915	0.000
E11.4 With neurological complications	0.065	0.934	0.000
Z88 Personal history of allergy to drugs, medicaments and biologocal substances	0.058	0.942	0.000
Z88.3 Personal history of allergy to other anti-infective agents	0.056	0.944	0.000
E66 Obesity	0.051	0.949	0.000
Z88.1 Personal history of allergy to other antibiotic agents	0.051	0.949	0.000
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances	0.050	0.950	0.000
Z42.0 Follow-up care involving plastic surgery of head and neck	0.000	0.952	0.048
Z88.8 Personal history of allergy to other drugs, medicaments and biological substances	0.048	0.952	0.000
Z88.4 Personal history of allergy to anaesthetic agent	0.044	0.956	0.000
Z88.7 Personal history of allergy to serum and vaccine	0.041	0.959	0.000
E11.5 With peripheral circulatory complications	0.038	0.961	0.001
E66.1 Drug-induced obesity	0.037	0.963	0.000
E66.0 Obesity due to excess calories	0.035	0.965	0.000
D86 Sarcoidosis	0.028	0.972	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.027	0.973	0.000
D86.9 Sarcoidosis, unspecified	0.027	0.973	0.000
D86.0 Sarcoidosis of lung	0.027	0.973	0.000
C43 Malignant melanoma of skin	0.000	0.974	0.026
D80-D89 Certain disorders involving the immune mechanism	0.025	0.975	0.000
D86.1 Sarcoidosis of lymph nodes	0.025	0.975	0.000
D52.9 Folate deficiency anaemia, unspecified	0.024	0.976	0.000
Z88.6 Personal history of allergy to analgesic agent	0.024	0.976	0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.023	0.977	0.000
E70-E90 Metabolic disorders	0.023	0.977	0.000
D52 Folate deficiency anaemia	0.022	0.978	0.000
D51 Vitamin B12 deficiency anaemia	0.022	0.978	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.000	0.978	0.022
D50-D53 Nutritional anaemias	0.022	0.978	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.000	0.978	0.021
D80 Immunodeficiency with predominantly antibody defects	0.021	0.979	0.000
D86.3 Sarcoidosis of skin	0.020	0.980	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.020	0.980	0.000
D82 Immunodeficiency associated with other major defects	0.020	0.980	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.020	0.980	0.000
D84 Other immunodeficiencies	0.020	0.980	0.000
C43.8 Overlapping malignant melanoma of skin	0.000	0.981	0.019
C43.0 Malignant melanoma of lip	0.000	0.981	0.019
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.019	0.981	0.000
E74 Other disorders of carbohydrate metabolism	0.019	0.981	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.019	0.981	0.000
D86.8 Sarcoidosis of other and combined sites	0.019	0.981	0.000
D83 Common variable immunodeficiency	0.019	0.981	0.000
D81 Combined immunodeficiencies	0.018	0.982	0.000
E80.4 Gilbert's syndrome	0.018	0.982	0.000
D53 Other nutritional anaemias	0.018	0.982	0.000
Z88.5 Personal history of allergy to narcotic agent	0.018	0.982	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.000	0.983	0.017
D80.1 Nonfamilial hypogammaglobulinaemia	0.017	0.983	0.000
D84.8 Other specified immunodeficiencies	0.017	0.983	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.017	0.983	0.000
E84 Cystic fibrosis	0.017	0.983	0.000
Z42 Follow-up care involving plastic surgery	0.000	0.983	0.017
C43.4 Malignant melanoma of scalp and neck	0.000	0.983	0.016
E77 Disorders of glycoprotein metabolism	0.016	0.983	0.000
E76 Disorders of glycosaminoglycan metabolism	0.016	0.983	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.016	0.983	0.000
E72 Other disorders of amino-acid metabolism	0.016	0.983	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.016	0.983	0.000
E70 Disorders of aromatic amino-acid metabolism	0.016	0.983	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.016	0.983	0.000
D82.1 Di George's syndrome	0.016	0.984	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.016	0.984	0.000
D52.8 Other folate deficiency anaemias	0.016	0.984	0.000
D52.1 Drug-induced folate deficiency anaemia	0.016	0.984	0.000
D52.0 Dietary folate deficiency anaemia	0.016	0.984	0.000
E79 Disorders of purine and pyrimidine metabolism	0.016	0.984	0.000
D51.8 Other vitamin B12 deficiency anaemias	0.016	0.984	0.000
D51.3 Other dietary vitamin B12 deficiency anaemia	0.016	0.984	0.000
D51.2 Transcobalamin II deficiency	0.016	0.984	0.000
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria	0.016	0.984	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.016	0.984	0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.016	0.984	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.015	0.985	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.015	0.985	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.015	0.985	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.015	0.985	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.015	0.985	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.015	0.985	0.000
E85 Amyloidosis	0.015	0.985	0.000
D84.1 Defects in the complement system	0.015	0.985	0.000
E73 Lactose intolerance	0.015	0.985	0.000
D53.9 Nutritional anaemia, unspecified	0.015	0.985	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.015	0.985	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.015	0.985	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.015	0.985	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.015	0.985	0.000
D82.2 Immunodeficiency with short-limbed stature	0.015	0.985	0.000
D82.0 Wiskott-Aldrich syndrome	0.015	0.985	0.000
D55-D59 Haemolytic anaemias	0.014	0.986	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.014	0.986	0.000
E80.5 Crigler-Najjar syndrome	0.014	0.986	0.000
E80.3 Defects of catalase and peroxydase	0.014	0.986	0.000
E80.1 Porphyria cutanea tarda	0.014	0.986	0.000
E80.0 Hereditary erythropoietic porphyria	0.014	0.986	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.014	0.986	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.014	0.986	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.014	0.986	0.000
E80.2 Other porphyria	0.014	0.986	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.014	0.986	0.000
D89.3 Immune reconstitution syndrome	0.014	0.986	0.000
D89.1 Cryoglobulinaemia	0.014	0.986	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.014	0.986	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.014	0.986	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.014	0.986	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.014	0.986	0.000
E74.2 Disorders of galactose metabolism	0.014	0.986	0.000
E74.1 Disorders of fructose metabolism	0.014	0.986	0.000
E74.0 Glycogen storage disease	0.014	0.986	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.014	0.986	0.000
D83.9 Common variable immunodeficiency, unspecified	0.014	0.986	0.000
D83.8 Other common variable immunodeficiencies	0.013	0.986	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.013	0.986	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.013	0.986	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.013	0.986	0.000
Z42.2 Follow-up care involving plastic surgery of other parts of trunk	0.000	0.986	0.014
D81.9 Combined immunodeficiency, unspecified	0.013	0.986	0.000
D81.8 Other combined immunodeficiencies	0.013	0.986	0.000
D81.7 Major histocompatibility complex class II deficiency	0.013	0.986	0.000
D81.6 Major histocompatibility complex class I deficiency	0.013	0.986	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.013	0.986	0.000
D81.4 Nezelof's syndrome	0.013	0.986	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.013	0.986	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.013	0.986	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.013	0.986	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.013	0.986	0.000
Z42.8 Follow-up care involving plastic surgery of other body part	0.000	0.987	0.013
C43.9 Malignant melanoma of skin, unspecified	0.000	0.987	0.013
E80.6 Other disorders of bilirubin metabolism	0.013	0.987	0.000
C43.5 Malignant melanoma of trunk	0.000	0.987	0.013
D53.8 Other specified nutritional anaemias	0.013	0.987	0.000
D53.2 Scorbutic anaemia	0.013	0.987	0.000
D53.1 Other megaloblastic anaemias, not elsewhere classified	0.013	0.987	0.000
D53.0 Protein deficiency anaemia	0.013	0.987	0.000
Z42.4 Follow-up care involving plastic surgery of lower extremity	0.000	0.987	0.013
Z42.9 Follow-up care involving plastic surgery, unspecified	0.000	0.987	0.013
D58 Other hereditary haemolytic anaemias	0.013	0.987	0.000
E84.9 Cystic fibrosis, unspecified	0.012	0.988	0.000
D60-D64 Aplastic and other anaemias	0.012	0.988	0.000
E84.8 Cystic fibrosis with other manifestations	0.012	0.988	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.012	0.988	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.012	0.988	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.012	0.988	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.012	0.988	0.000
E70.3 Albinism	0.012	0.988	0.000
E70.2 Disorders of tyrosine metabolism	0.012	0.988	0.000
E70.1 Other hyperphenylalaninaemias	0.012	0.988	0.000
E70.0 Classical phenylketonuria	0.012	0.988	0.000
E71.3 Disorders of fatty-acid metabolism	0.012	0.988	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.012	0.988	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.012	0.988	0.000
E71.0 Maple-syrup-urine disease	0.012	0.988	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.012	0.988	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.012	0.988	0.000
E72.5 Disorders of glycine metabolism	0.012	0.988	0.000
E72.4 Disorders of ornithine metabolism	0.012	0.988	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.012	0.988	0.000
E72.2 Disorders of urea cycle metabolism	0.012	0.988	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.012	0.988	0.000
E72.0 Disorders of amino-acid transport	0.012	0.988	0.000
E75.6 Lipid storage disorder, unspecified	0.012	0.988	0.000
E75.5 Other lipid storage disorders	0.012	0.988	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.012	0.988	0.000
E75.3 Sphingolipidosis, unspecified	0.012	0.988	0.000
E75.2 Other sphingolipidosis	0.012	0.988	0.000
E75.1 Other gangliosidosis	0.012	0.988	0.000
E75.0 GM2 gangliosidosis	0.012	0.988	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.012	0.988	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.012	0.988	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.012	0.988	0.000
E76.2 Other mucopolysaccharidoses	0.012	0.988	0.000
E76.1 Mucopolysaccharidosis, type II	0.012	0.988	0.000
E76.0 Mucopolysaccharidosis, type I	0.012	0.988	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.012	0.988	0.000
E77.8 Other disorders of glycoprotein metabolism	0.012	0.988	0.000
E77.1 Defects in glycoprotein degradation	0.012	0.988	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.012	0.988	0.000
E88 Other metabolic disorders	0.012	0.988	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.012	0.988	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.012	0.988	0.000
E79.1 Lesch-Nyhan syndrome	0.012	0.988	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.011	0.989	0.000
E85.8 Other amyloidosis	0.011	0.989	0.000
E85.3 Secondary systemic amyloidosis	0.011	0.989	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.011	0.989	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.011	0.989	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.011	0.989	0.000
D84.9 Immunodeficiency, unspecified	0.011	0.989	0.000
Z42.3 Follow-up care involving plastic surgery of upper extremity	0.000	0.989	0.011
E73.8 Other lactose intolerance	0.011	0.989	0.000
E73.1 Secondary lactase deficiency	0.011	0.989	0.000
E73.0 Congenital lactase deficiency	0.011	0.989	0.000
E85.9 Amyloidosis, unspecified	0.011	0.989	0.000
D58.2 Other haemoglobinopathies	0.011	0.989	0.000
D57 Sickle-cell disorders	0.010	0.989	0.000
D55 Anaemia due to enzyme disorders	0.010	0.989	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations